grant

CSRD Research Career Scientist Award Application

Organization VETERANS AFFAIRS MED CTR SAN FRANCISCOLocation SAN FRANCISCO, UNITED STATESPosted 1 Apr 2022Deadline 31 Mar 2027
VANIHUS FederalResearch GrantFY202565 and older65 or older65 years of age and older65 years of age or more65 years of age or older65+ years65+ years oldAD dementiaAdoptedAffectAgeAged 65 and OverAgingAirAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimers DementiaAmentiaAwardBehavior Conditioning TherapyBehavior ModificationBehavior TherapyBehavior TreatmentBehavioral Conditioning TherapyBehavioral ModificationBehavioral TherapyBehavioral TreatmentBrainBrain Nervous SystemCare GiversCaregiversCaringCausalityChemical ExposureChemical Warfare AgentsChemicalsClinical TrialsCognitionCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive function abnormalConditioning TherapyCongressesCounselingDegenerative Neurologic DisordersDementiaDepartment of DefenseDiagnosisDiseaseDisorderDisturbance in cognitionDrugsEmotionalEmployeeEncephalonEnvironmental ExposureEpidemiologic ResearchEpidemiologic StudiesEpidemiological StudiesEpidemiology ResearchEtiologyEvidence based treatmentExposure toFamilyFire - disastersFiresFrequenciesFundingGW veteranGeneral PopulationGeneral PublicGrantGulf WarGulf War IllnessGulf War SyndromeGulf War veteranHealthHealth CareHearingImpaired cognitionIncidenceIndividualInsecticidesInsomniaInsomnia DisorderIraqIraqiLeftLifeLife StyleLifestyleLinkMedical ResearchMedicationMissionNervous System Degenerative DiseasesNeural Degenerative DiseasesNeural degenerative DisordersNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Degenerative ConditionsNon-pharmacologic TherapyNonpharmacologic InterventionNonpharmacologic TherapyNonpharmacologic approachNonpharmacologic treatmentOilsOperation Desert ShieldOperation Desert StormOutcomeParalysis AgitansParkinsonParkinson DiseasePatient Self-ReportPersian Gulf SyndromePesticidesPharmaceutical PreparationsPrevalencePrimary ParkinsonismPrimary Senile Degenerative DementiaPublic HealthPublicationsPublishingReportingResearchResearch ActivityResearch SupportRiskScientific PublicationScientistSelf-ReportSeveritiesSideSleepSleep ApneaSleep Apnea SyndromesSleep HypopneaSleep disturbancesSleep-Disordered BreathingSleeplessnessSmokeSurvivorsSymptomsTreatment EfficacyVaccinesVeteransWorkaberrant sleepabove age 65after age 65age 65 and greaterage 65 and olderage 65 or olderageage groupage of 65 years onwardaged 65 and greateraged 65+aged ≥65agesbehavior interventionbehavioral interventionbrain atrophybrain volumecareercausationcerebral atrophychemical warfare substancesclinical diagnosisco-morbidco-morbiditycognitive dysfunctioncognitive functioncognitive losscohortcombatcomorbiditycortical atrophycostdegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdementia riskdisease causationdisrupted sleepdisturbed sleepdrug/agenteffective therapyeffective treatmentepidemiologic investigationepidemiology studyexperiencefirehuman old age (65+)impaired sleepimpressionimprovedintervention efficacyirregular sleepmild cognitive disordermild cognitive impairmentmotor symptomneural imagingneural mechanismneuro-imagingneurodegenerative illnessneuroimagingneurological imagingneuromechanismneuroprotectionneuroprotectiveneurotoxicologynon-drug therapynon-drug treatmentnon-motor symptomnondrug therapynondrug treatmentnonmotor symptomover 65 yearspesticide exposureprimary degenerative dementiaprogramsprophylacticquality of sleeprisk factor for dementiarisk for dementiasenile dementia of the Alzheimer typesite targeted deliverysleep disruptionsleep dysregulationsleep qualitysleep-related breathing disordersleep/wake disruptionsleep/wake disturbancetargeted deliverytherapeutic efficacytherapy efficacyyounger age≥65 years
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Dr. Linda Chao’s research has largely focused understanding Gulf War Illness (GWI) and improving
health outcomes in Gulf War (GW) Veterans. Her current research activities include investigating the long-

term consequences of GWI in the context of aging and neurodegenerative diseases. Epidemiological

research has linked environmental exposures, particularly pesticide exposure, to Parkinson’s disease (PD).

However, there has been no systematic research on incidence or prevalence of PD among GW veterans. Dr.

Chao’s current VA Merit grant (2I01CX000798-05) investigates the prevalence of PD and prodromal PD in

GW Veterans. Dr. Chao also has a newly funded Department of Defense (DOD)/Congressionally Directed

Medical Research Program (CDMRP) grant (W81XWH-21-0656) that investigates the prevalence and

etiology of Mild Cognitive Impairment (MCI) in GW Veterans. MCI is a condition where cognitive decline is

greater than expected for one’s age but is not yet severe enough to meet the criteria for dementia. Because MCI

has been linked to increased risk for dementia, this research will have a significant impact on VA Healthcare

because the precocious diagnosis of MCI, Alzheimer’s disease (AD), and PD in GW Veterans could

facilitate the targeted delivery of neuroprotective therapies when they become available. Furthermore, at-

risk Veterans may be counseled to adopt lifestyle changes that may lower their risk for these neurodegenerative

diseases.

Three decades after the end of the Gulf War, effective treatments for Gulf War Illness (GWI), the

multisymptomatic disorder estimated to affect 250,000 GW Veterans, remain elusive. Dr. Chao’s research has

investigated evidence-based treatments for GWI. Her recently completed VA Merit grant (I21CX001428)

showed that treating insomnia in GW Veterans non-pharmacologically with a behavioral intervention improved

both sleep and non-sleep symptoms of GWI. Because sleep apnea is commonly comorbid with insomnia, and

because many GW Veterans have untreated sleep apnea, Dr. Chao is expanding this research by investigating

the efficacy of an intervention that combines sleep apnea and insomnia treatment in her newly funded

DOD/CDMRP grant (W81XWH-21-1-0758).

Another major focus of Dr. Chao’s research is evaluating the neural mechanisms of non-pharmacological

interventions to delay onset or slow progression of cognitive impairment and dementia (recently

completed DOD/CDMRP grant W81XWH-17-1-0490; newly funded DOD/CDMRP grant W81XWH-21-1-0147).

Dementia prevalence is expected to triple worldwide over the next 40 years at tremendous monetary and

emotional cost. Considering that over 70% of Veterans are 50 years and older, and that Veterans 65 and older

are the fastest growing age group, this aspect of Dr. Chao’s research program will also have significant

impact and relevance on VA healthcare.

Grant Number: 5IK6CX002522-03
NIH Institute/Center: VA

Principal Investigator: Linda Chao

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →